Who We Are
Bellen Chemistry, established in 2007, originally focused on the design and development of hundreds of novel heterocycles. Over a number of years our innovative capabilities and reliable performance were gradually becoming more recognized in the marketplace, and our customers encouraged us to develop CRO/CDMO business with them.
In order to provide better solutions for our customers, the company has undertaken three rounds of venture capital financing to support our dynamic growth. A manufacturing plant has been constructed in Shandong in addition to a new process R&D center in Shanghai since 2017, and the capital investment is also enabling the relocation of our R&D innovation center to a new site in Beijing by end of 2020.
In the past 13 years the company has grown from 6 employees to over 500 employees. In line with our global service commitment, we have also set up Bellen branches in the US, UK, Canada, France and Japan so as to provide better and faster services to our local customers. Today we provide project support to a variety of different customers, from innovative biotech to global giant pharmaceutical companies.
Bellen is committed to continue investing in innovation and state-of-the-art facilities to enable an one-stop-shop chemistry service platform, adding value to your project from library synthesis to API GMP manufactory.
I truly appreciate the trust and support of all of our existing customers and I'm confident that Bellen will keep demonstrating high levels of performance and collaboration. We will continue investing and building our capabilities to enable the one-stop-shop chemistry service platform, adding value to your research and speeding up your discovery process. Bellen are extremely proud to be recognized by our global stakeholders as a business that is customer focused, innovative and passionate about authentic partnerships. Together, we will achieve great success in the near future...
Bob Liu, PhD
CEO of Bellen Chemistry
Bellen Chemistry has grown from
6 employees to more than 500 employees
globally and expanded services from novel
heterocycles design and supply to drug intermediate research, process
development and manufacturing that support over 1000 business partners around the world...
Bellen discharges its moral and legal obligations to IP, EHS, Quality and Compliance in a professional manner. Bellen continuously scans the business horizon and “designs in” effective risk management of new/emerging technologies and business models. Bellen demonstrates zero tolerance with respect to protection of Intellectual Property and is committed to global sustainability of environmental protection and safe working practices...
No. 1, Caida 3rd Street
ShunYi District, Beijing 101300, China